Title | Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care. |
Publication Type | Journal Article |
Year of Publication | 2023 |
Authors | Rao, SM, Galioto, R, Sokolowski, M, Pierce, M, Penn, L, Sturtevant, A, Skugor, B, Anstead, B, Leverenz, JB, Schindler, D, Blum, D, Alberts, JL, Posk, L |
Journal | J Alzheimers Dis |
Volume | 92 |
Issue | 3 |
Pagination | 1051-1066 |
Date Published | 2023 |
ISSN | 1875-8908 |
Keywords | Adolescent, Adult, Aged, Aged, 80 and over, Cognition, Cognitive Dysfunction, Humans, Middle Aged, Neuropsychological Tests, Primary Health Care, Reproducibility of Results, Young Adult |
Abstract | BACKGROUND: The self-administered iPad-based Cleveland Clinic Cognitive Battery (C3B) was designed specifically for the efficient screening of cognitive functioning of older adults in a primary care setting. OBJECTIVE: 1) Generate regression-based norms from healthy participants to enable demographic corrections to facilitate clinical interpretation; 2) estimate test-retest reliability and practice effects; 3) examine ability to discriminate mild cognitive impairment (MCI) from healthy aging; 4) d etermine validity of screening in a distracting clinical environment; and 5) determine completion rates and patient satisfaction in a primary care setting. METHODS: Study 1 (S1) recruited a stratified sample of 428 healthy adults, ages 18-89, to generate regression-based equations. S2 assessed 2-week test-retest reliability and practice effects in 30 healthy elders. S3 recruited 30 MCI patients and 30 demographically-matched healthy controls. In S4, 30 healthy elders self-administered the C3B in a distracting environment and in a quiet private room in counterbalanced order. In a demonstration project, 470 consecutive primary care patients were administered the C3B as part of routine clinical care (S5). RESULTS: C3B performance was primarily influenced by age, education, and race (S1), had acceptably high test-retest reliability and minimal practice effects (S2), discriminated MCI from healthy controls (S3), was not negatively impacted by a distracting clinical environment (S4), had high completion rates (>92%) and positive ratings from primary care patients (S5). CONCLUSION: The C3B is a computerized cognitive screening tool that is reliable, validated, self-administered, and is conducive to integration into a busy primary care clinical workflow for detecting MCI, early Alzheimer's disease, and other related dementias. |
DOI | 10.3233/JAD-220929 |
Alternate Journal | J Alzheimers Dis |
PubMed ID | 36847000 |
PubMed Central ID | PMC10116145 |
Grant List | P30 AG062428 / AG / NIA NIH HHS / United States |